PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23181523-7	2012	We then demonstrated the differential effect of memantine, an N-Methyl-D-aspartic acid (NMDA) subunit selective weak inhibitor, in early and late AD pathology, and show that inhibition of the NMDA receptor NR2C/NR2D subunits located on inhibitory interneurons compensates for the greater excitatory decline observed with pathology.	Memantine	48-57	glutamate ionotropic receptor NMDA type subunit 2C	Homo sapiens	206-210	
31555132-9	2019	The IC50 value of memantine as an NMDA antagonist is in micromolar range; the lowest limit is 112 ng/ml (GluN2C), and this value was achieved only in three cases.	Memantine	18-27	glutamate ionotropic receptor NMDA type subunit 2C	Homo sapiens	105-111